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Abstract 
In this case report, we describe the first PCR-confirmed case of HSV2 myeloradiculitis with a purely motor 
presentation, occurring in a 68-year-old liver transplant recipient. The patient reported ascending weakness 
with no sensory nor sphincteric symptoms, thereby resembling acute demyelinating inflammatory 
neuropathy, or Guillain-Barré syndrome. HSV2 was detected in cerebrospinal fluid by PCR, and the patient 
was successfully treated with intravenous Acyclovir. 
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Introduction 
 
 
Elsberg syndrome is an extremely rare lumbosacral infectious disorder characterized by involvement of the 
cauda equina and associated with Herpes Simplex virus type 2 (HSV2) reactivation or, infrequently, 
primary infection 1,2. Only 12 PCR-confirmed cases have been reported to date 2–6, and they all featured 
sphincterial and/or sensorimotor symptoms, while a purely motor presentation is not typical and occurs 
rarely. HSV2 disseminated infection is known to occur in transplant recipients as a result of reactivation of 
dormant virus or, rarely, in a donor-derived fashion, although a neurologic involvement has never been 
described7,8. We hereby describe the case of a 68-year-old immunocompromised man with progressive 
motor impairment due to HSV2 central nervous system (CNS) infection.. 
 
Clinical case 
 
 
The patient was admitted to our Emergency Department for a six-days history of progressive limb 
weakness. He reported a recent gastrointestinal illness with watery diarrhea, which lasted five days and 
disappeared after treatment with metronidazole. Six days after the resolution of the diarrhea, he started to 
experience progressive weakness of the lower limbs, with impairment in walking and climbing stairs, 
associated with lumbar pain and fatigue. He denied both sensory and autonomic or sphincteric deficits. 
Four days later, weakness of the hands appeared. 
His medical history was relevant for a liver transplant following acute HBV hepatitis at the age of 60. 
Seven years later, he was diagnosed with post-transplant large B-cell intestinal lymphoma and treated with 
jejunoileal resection. Since then, the patient had been receiving immunosuppressive treatment with 
Tacrolimus and Mofetil Mycophenolate, and antiviral treatment with anti-HbS Immunoglobulins and 
entecavir. 
Upon admittance, physical examination was unremarkable while neurological examination showed 
symmetric upper and lower limb weakness with proximal predominance, steppage gait, normal sensory 
testing and no sphincterial involvement. The remaining neurological examination, including cranial nerves, 
muscle tone, deep tendon reflexes (DTRs) and plantar cutaneous response, was normal. Blood tests were 
normal, except for leukocytosis (12.000 wbc/mm3) and elevated C-reactive protein (6 mg/dL). 
An urgent lumbar puncture was performed, revealing lymphocytic pleocytosis (250 cells/mm3, with T- 
lymphocyte prevalence), and normal proteins and glucose levels. Virologic analysis by PCR technology 
disclosed the presence of HSV-2 DNA (1700 copies of viral DNA) in cerebrospinal fluid (CSF). HSV1, 
VZV, EBV, CMV, HHV6, adenoviruses, enteroviruses, parvoviruses, Treponema Pallidum DNA were 
absent in the CSF. The patient reported no history of prior genital ulcers, and at the moment of evaluation 
there were no signs nor symptoms of genital HSV2 infection. 
  
Nerve conduction studies (NCS) showed normal amplitude, conduction velocity and distal latency in motor 
and sensory nerves at lower limbs, with preservation of F-waves (Table 1). Electromyography revealed 
reduced spatial recruitment in bilateral tibialis anterior, medial gastrocnemius and vastus medialis, along 
with increased amplitude and length of motor unit potentials (Table 1). 
Given the history of PTLD and the immunosuppression status, we decided to perform further investigations 
to exclude a possible reactivation. Cytologic and cytofluorimetric analysis on CSF showed mixed lymphoid 
cellularity, not consistent with the diagnosis of non-Hodgkin B-cell lymphoma. Given the strong  
association of PTLD with EBV infection, we searched for EBV-DNA presence on patient’s serum and  
CSF, which yielded negative results. Considering the strong epidemiological association of HSV-2  
infection with HIV infection, we tested our patient for HIV serology, which turned out negative9–11. 
We also performed a brain and spine MRI with gadolinium, which showed linear enhancement of cauda 
equina roots and of conus terminalis profile, in association with caudal roots enlargement (Figure 1). Brain 
MRI was unremarkable. 
 
The discovery of CSF HSV-2 positivity raised suspicion for HSV-2 myeloradiculitis, or Elsberg   
syndrome1. Limited evidence suggests that acyclovir may be effective in the treatment of this condition1,4. 
Notwithstanding that some authors advocate the use of corticosteroids as the mainstay for halting immune- 
mediated inflammation and reducing long-term sequelae4, evidence regarding their effectiveness and safety 
is still lacking1. Therefore, a therapeutic course with Acyclovir 10 mg/kg three times daily was started, with 
progressive improvement in clinical symptoms. NCS performed one week later revealed a reduction in the 
amplitude of the compound muscle action potential in both posterior tibial nerves, suggesting the occurrence 
of axonal damage in motor nerves and roots, which was expected. 
A repeat lumbar puncture showed a reduction of lymphocytic count and absence of HSV-2 DNA in the 
CSF, thereby treatment was discontinued after 21 days. Given the potential risk for reactivation, oral 
prophylactic treatment with 400 mg of oral acyclovir twice a day was started. At discharge, the patient 
presented an improvement in motor function, especially in distal regions, and was able to walk 
independently. The patient was reviewed in our clinic after two months, and his symptoms appeared to be 
further ameliorated. He could walk independently, stand up from sitting position with the aid of upper limbs, 
and climb stairs with the aid of a handrail. His motor strength was normal in the upper limbs, while a    
slight residual weakness could be appreciated in the lower limbs. 
 
Discussion 
  
HSV-2 is a diffuse anogenital infection which may rarely cause neurological complications, especially in 
immunocompromised patients. Meningitis, encephalitis, and myeloradiculitis, also called Elsberg 
syndrome, are all potential manifestations of the disease1–4,12–15. Compared to immunocompetent patients, 
solid organ transplant recipients present a higher risk for HSV2 disease, and they generally show more 
frequent and severe clinical manifestations7,16. In most cases, symptomatic infection results from 
reactivation of latent virus, although primary infection from allograft or from interpersonal transmission 
may occur7,8. Our patient reported no history of prior genital ulcers. 
 
Reported manifestations of visceral or disseminated HSV2 infection in transplant recipients feature 
hepatitis, pneumonitis, disseminated cutaneous disease, leucopenia and fever, while a CNS involvement in 
these patients has never been described7,8,16. However, clinical presentation in immunocompromised patient 
is often atypical, therefore different aetiological agents may lack typical findings that are otherwise 
expected. 
In previously described cases of HSV2 myeloradiculitis, sexual and sphincter dysfunction, sensory 
symptoms and flaccid paresis in a variable distribution are usually observed, with acute or subacute onset 
and course1,3,4. Pure motor presentations have been described rarely. In a recent report, Shields and 
colleagues described a woman with severe lower limbs weakness and urinary hesitancy due to HSV2 
radiculomyelitis17. In a previous series, urinary retention was reported by 77%, saddle anesthesia by 50%, 
bowel incontinence by 10% and constipation by 43% of patients1, while sensory loss affecting the limbs 
was reported by 80% of patients. Prodromal symptoms, such as fever, headache, photophobia, diarrhea, 
myalgia, and general malaise, have been described in 17% of patients in the aforementioned series1. Our 
patient reported watery diarrhea prior to the onset of weakness. 
Myelopathy may show a gradual ascension to cervicothoracic spinal cord levels, associated, in some cases, 
to a necrotizing evolution with a severe prognosis 4,9,10. Immunosuppressive conditions, such as diabetes, 
HIV infection, and neoplasms, seem to be predisposing risk factors for this peculiar variant. 
As regards CSF analysis, a retrospective study found that median CSF leukocyte count was 9/μL, while 
median CSF proteins were 143 ± 131 mg/dL 2. 
 
In this case, the absence of sensory and autonomic symptoms broadened the potential differential diagnoses 
(Table 2). Ascending weakness associated with back pain is highly suggestive for Guillain-Barré syndrome 
(GBS), an acute immune-mediated polyneuropathy, which causes a monophasic illness with symmetric 
cranial or limb weakness, sometimes accompanied by distal paresthesias. GBS typically follows a 
gastrointestinal infection and it is almost invariably associated with reduced DTRs, absent F waves on  
nerve conduction studies (NCS) and CSF albumin-cytological dissociation. The symptoms of our patient 
  
raised suspicion for GBS, although some features were not typical, such as the presence of normal DTRs, 
the preservation of F waves at electroneurographic studies and the elevated pleocytosis in CSF. 
 
Furthermore, it was of paramount importance to exclude a central nervous system (CNS) recurrence of 
large B-cell lymphoma. Post-transplant lymphoproliferative disorders (PTLD) are 
lymphoid and/or plasmacytic proliferations occurring after solid organ or allogeneic hematopoietic cell 
transplantation as a result of immunosuppression. They are among the most serious and potentially fatal 
complications of transplantation. While the majority appears to be related to the presence of Epstein-Barr 
virus (EBV), EBV-negative disease may happen 18. CNS PTLD are uncommon, and diagnostic tests 
include magnetic resonance imaging (MRI) with gadolinium, cerebrospinal fluid (CSF) analysis for EBV 
by polymerase chain reaction (PCR) and cytology with flow cytometry 1. Our patient experienced a post- 
transplant, EBV-negative large B-cell lymphoma one year before the onset of the symptoms described, 
therefore a neurologic localization of the disease should be considered in the differential diagnosis, despite 
follow-up after surgical resection yielded negative results. 
 
In case of clinical uncertainty, consistent MRI findings might support the diagnosis of infectious 
myeloradiculitis. Despite no pathognomonic or specific neuroimaging features for HSV-2 myeloradiculitis 
were identified, there are some typical findings1. Multiple and often discontinuous spinal cord lesions can 
be observed, usually with a central or ventral distribution. In addition, nerve roots and/or lower spinal cord 
edema with T2-hyperintensity may occur at lumbosacral MRI, accompanied by contrast enhancement in 
the acute phase of infection1,4,5. 
To aid clinicians in the diagnosis, clinical and laboratory-supported criteria, with 5 levels of diagnostic 
certainty, have been proposed by Savoldi and colleagues1. These criteria require clinical, 
electrophysiological or MRI evidence of radiculitis for the diagnosis to be made, associated with either 
laboratory confirmation of viral DNA in the CSF or presence of supportive criteria and absence of 
exclusionary criteria. Our patient met both the criteria for both “Laboratory-supported definite” and 
“Clinically definite” levels of certainty. 
 
Although no definitive evidence from controlled trials is available, antiviral treatment with Acyclovir 
appeared to be beneficial in retrospective studies and anecdotal reports, and should be started as early as 
possible 2,4,8. Recommended dosage in visceral HSV2 infection is 5-10 mg/kg intravenously every 8 hours 
(Grade II-1)7. During Acyclovir therapy, kidney function needs to be monitored daily, and antiviral dose 
must be adjusted if creatinine clearance falls below 50 milliliters per minute. Outcome varies according to 
the severity of the underlying disease, with milder cases showing almost complete remission, while severe 
or necrotizing forms generally hesitate in permanent disability or, rarely, death 2,4,8. 
  
Thus, this case points out that in the presence of progressive limb weakness, even in the absence of sensory 
levels and bladder dysfunction or fever, an infectious disease of the spinal cord cord/roots, with particular 
attention to herpetic infections, should be included in the differential diagnosis. Clinicians should bear in 
mind the extreme heterogeneity of clinical features in transplant recipients, and infections from potentially 
treatable agents should be thoroughly excluded. In the case series by Savoldi and colleagues, almost half of 
the patients meeting criteria were not checked for HSV2, even though lumbar puncture was performed, 
highlighting a knowledge gap in contemporary clinical practice. 
 
In conclusion, our case expands the spectrum of manifestations associated with HSV2 CNS infection, and 
highlights the paramount importance of taking into account this potential cause of ascending weakness, so 
to avoid overlooking the diagnosis of a potentially serious, but treatable, infectious disease. 
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Figure legend 
 
 
Figure 1. Spinal Magnetic Resonance Imaging (MRI) 
Fat Sat T1 MRI images post-Gad (A-B-C coronal view and E-F-G sagittal view) showing a pathological 
enhancement on the nerve roots of the cauda equina (white arrows). The fat suppression of the sequence 
allows a better detection of the finding. 
 
Table legend 
 
 
Table 1. Lower limbs motor and sensory nerve conductions studies (NCS). 
First (I) and second (II) electrophysiological exams performed 6 and 13 days after the onset of progressive 
limb weakness, respectively. Normal amplitude, conduction velocity and distal latency in motor and 
sensory nerves were observed at the first NCS. F-waves were present and with normal latency. A reduction 
in motor amplitude of the compound muscle action potential (CMAP) in both posterior tibial nerves was 
found at the second NCS, suggesting the occurrence of axonal damage involving motor nerves and roots. 
Left sural nerves conduction was normal. 
 
 
Motor conduction studies I II 
Right posterior tibial nerve 
Distal latency (ankle) 
 
4.1 ms 
 
3.6 ms 
Amplitude (ankle) 
Amplitude (knee) 
Conduction velocity 
F-wave latency 
Left posterior tibial nerve 
Distal latency (ankle) 
Amplitude (ankle) 
Amplitude (knee) 
Conduction velocity 
F-wave latency 
7.3 mV 
6.4 mV 
42.9 m/s 
47.3 ms 
 
 
4.0 ms 
9.4 mV 
6.4 mV 
41.4 m/s 
- 
2.7 mV 
1.6 mV 
43.8 m/s 
49.6 ms 
 
 
3.6 ms 
2.0 mV 
1.6 mV 
46.6 m/s 
50.2 ms 
Sensory conduction studies I II 
Left sural nerve   
Amplitude 6 µV 7 µV 
Conduction velocity 48.3 m/s 46.9 m/s 
  
Normal values. Posterior tibial nerve: distal latency < 6 ms; amplitude > 4 mV; conduction velocity > 42 
m/s; F-wave latency < 58 ms. Sural nerve: amplitude > 4 mV; conduction velocity > 44 m/s. 
 
 
 
Table 2. Differential diagnosis of acute bilateral weakness 
 
Brainstem 
Brainstem encephalitis 
Bulbar infarct 
Brainstem compression 
 
Spinal cord 
Immune myelitis (multiple sclerosis, NMOSD) 
Vascular myelopathy (spinal infarct, LES, anti-phospholipid syndrome, vasculitis) 
Infectious myelopathy (poliovirus, other enteroviruses, West Nile virus, CMV, VZV, EBV, 
Mycobacterium tuberculosis) 
Compressive myelopathy (intrinsic – spinal tumor, metastases -, extrinsic) 
Carcinomatous meningitis 
 
Nerve roots or plexus 
Diabetic radiculopathy/plexopathy 
Radiation plexopathy 
Inflammatory polyradiculoneuropathy (GBS, acute onset CIDP, sarcoidosis) 
Infectious diseases (Borrelia burgdorferi, CMV, EBV, HSV1/2, VZV, Mycobacterium tuberculosis, 
Mycoplasma, Syphilis, HIV) 
Malignancies (lymphoma, metastases, multiple myeloma) 
Vascular (Arteriovenous malformation, Radiation-induced vascular occlusion, Vasculitis) 
 
Peripheral nerves 
Inflammatory neuropathy (GBS, acute onset CIDP, sarcoidosis) 
Toxic neuropathy (alcoholic neuropathy, arsenic poisoning, n-hexane in glue sniffing neuropathy, acute 
uremic neuropathy, iatrogenic) 
Critical illness neuropathy 
Acute severe vitamin B1 (thiamine) deficiency 
Electrolyte disorders (hypokalaemia, phosphataemia or magnesaemia, hypoglycaemia) 
  
 
Infectious neuropathy (Borrelia burgdorferi, tick paralysis, HIV) 
Acute intermittent porphyria 
Vasculitis 
 
Neuromuscular junction 
Myasthenia 
Botulism 
Acute organophosphate poisoning 
Lambert-Eaton myasthenic syndrome 
 
Muscles 
Acute inflammatory myopathy 
Critical illness myopathy 
Periodic hypo/hyperkaliemic palsy 
 
Abbreviations: CIDP, chronic inflammatory demyelinating neuropathy; CMV, Cytomegalovirus; EBV, 
Epstein Barr virus; GBS, Guillain-Barrè syndrome; HIV, Human immunodeficiency virus; HSV, Herpes 
simplex virus; LES, Lupus erythematosus systemicus; NMOSD, Neuromyelitis optica spectrum disorders; 
VZV, Varicella zoster virus. 
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